Publications by authors named "Holger Moch"

Are you Holger Moch?   Register this Author

Multi-laboratory proficiency testing of clinical cancer genomic profiling by next-generation sequencing.
Pathol Res Pract 2018 May 22. Epub 2018 May 22.
Department of Pathology and Molecular Pathology, University Hospital Zurich, 8091, Zurich, Switzerland; Senckenberg Institute of Pathology, University Hospital Frankfurt, 60590, Frankfurt, Germany. Electronic address:

Comprehensive immunohistochemical analysis of PD-L1 shows scarce expression in castration-resistant prostate cancer.
Oncotarget 2018 Feb 4;9(12):10284-10293. Epub 2017 Dec 4.
Department of Pathology and Molecular Pathology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

Targeting the Programmed Cell Death-1 Pathway in Genitourinary Tumors: Current Progress and Future Perspectives.
Curr Drug Metab 2017 Oct;18(8):700-711
Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, 350 West 11th Street, IUHPL Room 4010, Indianapolis, IN 46202. United States.

Diagnostic Accuracy of Quantitative and Qualitative Phase-Contrast Imaging for the ex Vivo Characterization of Human Coronary Atherosclerotic Plaques.
Radiology 2015 Oct 5;277(1):64-72. Epub 2015 May 5.
From the Institute of Diagnostic and Interventional Radiology (S.W., F.M., M.v.W., H.A., P.S.) and Institute of Pathology (V.T., L.B., H.M.), University Hospital Zurich, Raemistrasse 100, 8091 Zurich, Switzerland; Department of Forensic Medicine and Radiology, Institute of Forensic Medicine, University of Zurich, Zurich, Switzerland (S.W., S.B., M.T., P.S.); Swiss Light Source, Paul Scherrer Institute, Villigen, Switzerland (S.P., P.M., M.S.); and Institute for Biomedical Engineering, University and ETH Zurich, Zurich, Switzerland (S.P., M.S.).

Clear cell papillary renal cell carcinoma and renal angiomyoadenomatous tumor: two variants of a morphologic, immunohistochemical, and genetic distinct entity of renal cell carcinoma.
Am J Surg Pathol 2015 Jul;39(7):889-901
*Institute of Surgical Pathology, University Hospital Zurich, Zurich ‡‡Cantonal Hospital Aarau §§Institute of Histological and Cytological Diagnostics, Aarau ¶¶University Institute of Pathology, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland †Institute of Pathology, University Medicine Göttingen (UMG), Göttingen ∥Institute of Pathology, University Hospital Tübingen, Tübingen ¶Institute of Pathology, HELIOS Hospital Berlin-Buch, Berlin #Institute of Pathology Bogenhausen, Städtisches Klinikum München GmbH, Munich **Institute of Pathology, Heinrich Heine University Hospital, Dusseldorf ††Institute of Pathology, RWTH University, Aachen ∥∥Institute of Pathology, HELIOS Hospital Schwerin, Schwerin ***Institute of Pathology, Städtisches Klinikum Karlsruhe gGmbH, Karlsruhe †††Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany ‡Service d'Anatomie et Cytologie Pathologiques 1, Groupe Hospitalier Pitié-Salpêtrière, Paris, France §Department of Medicine, Renal Division, Brigham and Women's Hospital, Boston, MA ##Institute of Pathology, University of Florence, Florence, Italy.

Changes in autopsy rates among cancer patients and their impact on cancer statistics from a public health point of view: a longitudinal study from 1980 to 2010 with data from Cancer Registry Zurich.
Virchows Arch 2015 Jun 7;466(6):637-43. Epub 2015 Mar 7.
Division of Chronic Disease Epidemiology, Epidemiology, Biostatistics and Prevention Institute (EPBI), University of Zurich, Hirschengraben 84, 8001, Zürich, Switzerland.

Tall cell papillary thyroid carcinoma: new diagnostic criteria and mutations in BRAF and TERT.
Endocr Relat Cancer 2015 Jun 13;22(3):419-29. Epub 2015 Apr 13.
Institute of PathologyUniversity of Bern, Murtenstrasse 31, 3010 Bern, SwitzerlandDivision of Nuclear MedicineUniversity Hospital Zurich, Zurich, SwitzerlandDepartment of NeuropathologyInstitute of Pathology, German Cancer Research Center (DKFZ), Ruprecht-Karls University, and Clinical Cooperation Unit Neuropathology, Heidelberg, GermanyInstitute of Surgical PathologyUniversity Hospital Zurich, Zurich, SwitzerlandInstitute of Surgical PathologyTriemlispital, Zürich, Switzerland.

Insulin-like growth factor I is expressed in classical and nodular lymphocyte-predominant Hodgkin's lymphoma tumour and microenvironmental cells.
Cell Tissue Res 2015 Mar 9;359(3):841-51. Epub 2014 Dec 9.
Research Group Neuro-endocrine-immune Interactions, Institute of Anatomy, University of Zurich, Zurich, Switzerland,

Fullerenols and glucosamine fullerenes reduce infarct volume and cerebral inflammation after ischemic stroke in normotensive and hypertensive rats.
Exp Neurol 2015 Mar 24;265:142-51. Epub 2015 Jan 24.
Department of Biomolecular Systems, Max Planck Institute of Colloids and Interfaces, 14476 Potsdam, Germany; Institute for Chemistry and Biology, Freie Universität Berlin, 14195 Berlin, Germany.

Multicenter immunohistochemical ALK-testing of non-small-cell lung cancer shows high concordance after harmonization of techniques and interpretation criteria.
J Thorac Oncol 2014 Nov;9(11):1685-92
*Institute of Pathology, Charité BERLIN, Berlin, Germany; †Institute of Pathology, University of Heidelberg, Heidelberg, Germany; ‡Department of Pathology, Aberdeen University Medical School, Aberdeen, United Kingdom; §Department of Pathology and Cytology, Karolinska University Hospital, Solna, Stockholm, Sweden; ‖Department of Pathology, University Hospital Cologne, Cologne, Germany; ¶Laboratorio de Dianas Terapeuticas, Hospital Universitario Sanchinarro, Madrid, Spain; #Institute of Pathology, Klinikum Großhadern Ludwig-Maximilians-Universität, Munich, Germany; **Institute of Pathology, UZ ANTWERPEN, Edegem, Belgium; ††Institute of Pathology, Klinikum rechts der Isar, TU, Munich, Germany; ‡‡Institute of Pathology, University Hospital Carl Gustav Carus, Dresden, Germany; §§Institute of Pathology, Universitätsspital Basel, Basel, Germany; ‖‖Institute of Pathology, HSK Dr.-Horst-Schmidt-Kliniken GmbH, Wiesbaden, Germany; ¶¶Institute of Pathology, Universitäts Spital Zürich, Zurich, Switzerland; ##Institute of Pathology, Centre Jean Perrin, Clermont-Ferrand, France; ***Patologisk Institut, Århus Universitetshospital, Århus, Denmark; †††Pathology-Berlin, Bioptisches Institut Gemeinschaftspraxis für Pathologie, Berlin, Germany.

Hif-2α promotes degradation of mammalian peroxisomes by selective autophagy.
Cell Metab 2014 Nov 4;20(5):882-897. Epub 2014 Nov 4.
Institute of Molecular Health Sciences, ETH Zurich, CH-8093 Zurich, Switzerland; Competence Center for Systems Physiology and Metabolic Diseases, ETH Zurich, CH-8093 Zurich, Switzerland. Electronic address:

Modelling of a genetically diverse evolution of Systemic Mastocytosis with Chronic Myelomonocytic Leukemia (SM-CMML) by Next Generation Sequencing.
Exp Hematol Oncol 2014 11;3:18. Epub 2014 Jul 11.
Institute of Surgical Pathology, University Hospital Zurich, Zurich, Switzerland ; Kempf and Pfaltz, Histological Diagnostics, Seminarstr. 1, 8042 Zurich, Switzerland.

Diagnostic criteria for oncocytic renal neoplasms: a survey of urologic pathologists.
Hum Pathol 2017 05 14;63:149-156. Epub 2017 Mar 14.
Department of Pathology and Laboratory Medicine, Detroit, MI, 48202, United States; Henry Ford Cancer Institute, Henry Ford Health System, Detroit, MI, 48202, United States.

Computed Tomography Radiomics Predicts HPV Status and Local Tumor Control After Definitive Radiochemotherapy in Head and Neck Squamous Cell Carcinoma.
Int J Radiat Oncol Biol Phys 2017 11 15;99(4):921-928. Epub 2017 Jun 15.
Department of Radiation Oncology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.